4/A: NeoGenomics CEO Corrects Stock Ownership After RSU Vesting
SEC Form 4 Amendment
NeoGenomics CEO Christopher M. Smith amended a previous filing to correct the number of shares owned after restricted stock units vested and shares were withheld for taxes.
Summary
- This document is an amended SEC Form 4 filing by Christopher M. Smith, CEO of NeoGenomics Inc.
- The amendment corrects a previous filing from May 14, 2024, which incorrectly reported the number of shares owned after the vesting of restricted stock units (RSUs).
- On May 11, 2024, 48,063 RSUs vested, converting into common stock.
- A portion of the vested shares, specifically 18,913 shares, were withheld to cover tax obligations at a price of $14.86 per share.
- After the transaction, Mr. Smith directly owns 631,369 shares of NeoGenomics common stock.
- The original error also affected subsequent Form 4 filings by the reporting person.
Sentiment
Score: 5
Explanation: The document is a correction of a previous error, which is neutral to slightly negative. It does not indicate any positive or negative business performance, but the error is a minor concern.
Negatives
- The initial Form 4 filing on May 14, 2024, contained an error in reporting the number of shares owned.
- This error also affected subsequent Form 4 filings by the reporting person.
Risks
- Errors in reporting stock ownership can lead to confusion and potential regulatory scrutiny.
- Inaccurate filings can impact investor confidence.
Industry Context
This type of filing is standard for company executives who receive stock-based compensation. It is important for transparency and regulatory compliance.
Comparison to Industry Standards
- The reporting of stock transactions by executives is a common practice across all publicly traded companies.
- The use of Form 4 filings is a standard requirement by the SEC to ensure transparency in insider trading.
- The vesting of restricted stock units is a typical form of executive compensation, and the tax withholding process is also standard.
Stakeholder Impact
- The correction of the filing ensures accurate information for shareholders.
- The correction may have a minor impact on investor confidence due to the initial error.
Key Dates
| Date | Description |
|---|---|
| 05/11/2023 | Mr. Smith was granted 144,190 restricted stock units. |
| 05/11/2024 | 48,063 restricted stock units vested and converted to common stock; shares were withheld for taxes. |
| 05/14/2024 | Original Form 4 filing with incorrect share count. |
| 12/03/2024 | Date of the amended Form 4/A filing. |
Keywords
SEC Form 4, Beneficial Ownership, Restricted Stock Units, RSU Vesting, Stock Ownership, NeoGenomics, Christopher M. Smith, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.